Some aspects of diuretic therapy.
D000368:Aged; D000584:Amiloride / Q000627:therapeutic use; D001581:Benzothiadiazines; D004071:Digitalis Glycosides / Q000506:poisoning; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D007008:Hypokalemia / Q000139:chemically induced / Q000517:prevention & control; D008275:Magnesium Deficiency / Q000139:chemically induced; D008297:Male; D011188:Potassium / Q000627:therapeutic use; D011189:Potassium Chloride / Q000627:therapeutic use; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use
D001581:Benzothiadiazines; D004071:Digitalis Glycosides; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D013148:Spironolactone; D011189:Potassium Chloride; D000584:Amiloride; D005665:Furosemide; D004976:Ethacrynic Acid; D011188:Potassium